AngioDynamics (NASDAQ:ANGO – Get Free Report) had its target price reduced by analysts at Canaccord Genuity Group from $18.00 to $16.00 in a note issued to investors on Monday,Benzinga reports. The firm presently has a “buy” rating on the medical instruments supplier’s stock. Canaccord Genuity Group’s target price points to a potential upside of 62.35% […]

Intuitive Surgical (NASDAQ:ISRG – Get Free Report) had its price objective cut by stock analysts at Evercore from $550.00 to $480.00 in a report released on Monday,MarketScreener reports. The brokerage currently has a “neutral” rating on the medical equipment provider’s stock. Evercore’s price target indicates a potential upside of 5.14% from the company’s previous close. […]

The Berkeley Group (LON:BKG – Get Free Report) had its target price reduced by research analysts at JPMorgan Chase & Co. from GBX 5,000 to GBX 4,200 in a research note issued on Thursday,London Stock Exchange reports. The brokerage currently has an “overweight” rating on the stock. JPMorgan Chase & Co.‘s price objective points to […]

SEALSQ (NASDAQ:LAES – Get Free Report) had its price target reduced by equities research analysts at Cantor Fitzgerald from $7.00 to $4.00 in a research report issued to clients and investors on Thursday,Benzinga reports. The brokerage presently has an “overweight” rating on the stock. Cantor Fitzgerald’s target price would indicate a potential upside of 71.45% […]

Vivani Medical (NASDAQ:VANI – Get Free Report) had its target price cut by equities research analysts at HC Wainwright from $4.00 to $3.50 in a report issued on Tuesday,Benzinga reports. The firm presently has a “buy” rating on the stock. HC Wainwright’s price target points to a potential upside of 250.00% from the stock’s previous […]

Global-e Online (NASDAQ:GLBE – Get Free Report) had its price objective cut by equities research analysts at UBS Group from $52.00 to $50.00 in a research report issued on Tuesday,Benzinga reports. The firm presently has a “buy” rating on the stock. UBS Group’s price objective would indicate a potential upside of 62.07% from the stock’s […]

UMB Financial (NASDAQ:UMBF – Get Free Report) had its price objective dropped by equities researchers at Morgan Stanley from $156.00 to $143.00 in a report issued on Tuesday,Benzinga reports. The firm currently has an “overweight” rating on the bank’s stock. Morgan Stanley’s target price suggests a potential upside of 26.75% from the stock’s current price. […]

Derwent London (LON:DLN – Get Free Report) had its price objective dropped by investment analysts at Stifel Nicolaus from GBX 1,925 to GBX 1,650 in a note issued to investors on Tuesday,London Stock Exchange reports. The brokerage currently has a “hold” rating on the real estate investment trust’s stock. Stifel Nicolaus’ price objective points to […]

USA Rare Earth (NASDAQ:USAR – Get Free Report) had its price target cut by investment analysts at Canaccord Genuity Group from $33.00 to $29.00 in a research note issued to investors on Tuesday,Benzinga reports. The firm presently has a “buy” rating on the stock. Canaccord Genuity Group’s price target points to a potential upside of […]

Unite Group (LON:UTG – Get Free Report) had its target price dropped by equities researchers at The Goldman Sachs Group from GBX 680 to GBX 620 in a report issued on Monday,London Stock Exchange reports. The brokerage currently has a “buy” rating on the stock. The Goldman Sachs Group’s price objective would indicate a potential […]

Tilray Brands (NASDAQ:TLRY – Get Free Report) had its target price decreased by research analysts at TD Cowen from $10.00 to $7.00 in a report issued on Monday,Benzinga reports. The brokerage currently has a “buy” rating on the stock. TD Cowen’s target price points to a potential upside of 10.76% from the stock’s current price. […]

Bruker (NASDAQ:BRKR – Get Free Report) had its target price reduced by Guggenheim from $58.00 to $50.00 in a research report issued on Monday,Benzinga reports. The brokerage currently has a “buy” rating on the medical research company’s stock. Guggenheim’s price target indicates a potential upside of 44.74% from the company’s previous close. A number of […]

Navan (NASDAQ:NAVN – Get Free Report) had its target price reduced by analysts at Citigroup from $26.00 to $21.00 in a research note issued on Thursday,Benzinga reports. The brokerage currently has a “buy” rating on the stock. Citigroup’s price target would indicate a potential upside of 79.61% from the stock’s current price. NAVN has been […]